696O_PR Nivolumab + cabozantinib vs sunitinib in first-line treatment for advanced renal cell carcinoma: First results from the randomized phase III CheckMate 9ER trial
Choueiri, T.K., Powles, T., Burotto, M., Bourlon, M.T., Zurawski, B., Oyervides Juárez, V.M., Hsieh, J.J., Basso, U., Shah, A.Y., Suarez, C., Hamzaj, A., Barrios, C.H., Richardet, M., Pook, D., Tomita, Y., Escudier, B., Zhang, J., Simsek, B., Apolo, A.B., Motzer, R.J.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Severe Genitourinary Events Following Definitive Radiation Therapy for Patients with Locally Advanced and Metastatic Bladder Cancer: A Single Institution Experience
Carriere, P.P., Alhalabi, O., Gao, J., Campbell, M., Kamat, A., Navai, N., Lee, B., Bree, K., Hoffman, K.E., Tang, C., Mohamad, O., Mok, H., Mayo, L.L., Goswami, S., Shah, A.Y., Adibi, M., McGuire, S.E., Shah, S.J., Choi, S., Hassanzadeh, C.J.
Published in International journal of radiation oncology, biology, physics (01.10.2024)
Published in International journal of radiation oncology, biology, physics (01.10.2024)
Get full text
Journal Article
Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors
Shah, A.Y., Kotecha, R.R., Lemke, E.A., Chandramohan, A., Chaim, J.L., Msaouel, P., Xiao, L., Gao, J., Campbell, M.T., Zurita, A.J., Wang, J., Corn, P.G., Jonasch, E., Motzer, R.J., Sharma, P., Voss, M.H., Tannir, N.M.
Published in European journal of cancer (1990) (01.06.2019)
Published in European journal of cancer (1990) (01.06.2019)
Get full text
Journal Article
678P Cytoreductive nephrectomy (CN) for patients with metastatic sarcomatoid and/or rhabdoid (S/R) renal cell carcinoma (RCC) treated with immune checkpoint inhibitors (ICI)
Hahn, A.W., Viscuse, P.V., Pieretti, A., Wiele, A.J., Jonasch, E., Gao, J., Zurita, A.J., Shah, A.Y., Campbell, M.T., Sharma, P., Wood, C.G., Tannir, N.M., Karam, J.A., Msaouel, P.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
Definitive Local Consolidative Therapy for Oligometastatic Solid Tumors: Results from the Lead-In Phase of the Randomized Basket Trial EXTEND
Sherry, A.D., Bathala, T., Liu, S., Chun, S.G., Jasani, N., Guadagnolo, B.A., Holliday, E., Jhingran, A., Reddy, J.P., Corn, P.G., Shah, A.Y., Fellman, B., Kaiser, K.W., Ghia, A.J., Gomez, D.R., Tang, C.
Published in International journal of radiation oncology, biology, physics (01.11.2022)
Published in International journal of radiation oncology, biology, physics (01.11.2022)
Get full text
Journal Article
663P First-line nivolumab + cabozantinib vs sunitinib in patients (pts) with advanced renal cell carcinoma (aRCC) in subgroups based on prior nephrectomy in the CheckMate 9ER trial
Porta, C.G., Burotto, M., Suarez Rodriguez, C., Bourlon, M.T., Hsieh, J., Shah, A.Y., Hamzaj, A., Bedke, J., Pook, D., Kessler, E.R., Tomita, Y., Drakaki, A., Zhang, J., Simsek, B., Schwab, G., Escudier, B., Motzer, R.J., Choueiri, T.K., Apolo, A.B., Powles, T.B.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
Real world treatment costs and resource utilization among patients with metastatic bladder cancer
Flannery, K., Cao, X., He, J., Zhong, Y., Shah, A.Y., Kamat, A.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Lenvatinib (Len) alone or in combination with everolimus (Eve) in heavily pretreated patients (pts) with metastatic renal cell carcinoma (mRCC) after immune checkpoint inhibitors (ICI) and VEGFR-targeted therapies: A single-institution experience
Wiele, A.J., Ross, J., Chahoud, J., Lim, Z., Xiao, L., Campbell, M.T., Shah, A.Y., Zurita Saavedra, A., Jonasch, E., Tannir, N.M.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Initial results of a phase II study of nivolumab and ipilimumab in metastatic adrenal tumours
Campbell, M.T., Xie, W., Shah, A.Y., Habra, M.A., Jimenez, C., Venkatesan, A.M., Bubley, G., McKay, R.R., Choueiri, T.K., McGregor, B.A., Killbridge, K.L., Mortazavi, A., Bilen, M.A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
986P - Initial results of a phase II study of nivolumab and ipilimumab in metastatic adrenal tumours
Campbell, M.T., Xie, W., Shah, A.Y., Habra, M.A., Jimenez, C., Venkatesan, A.M., Bubley, G., McKay, R.R., Choueiri, T.K., McGregor, B.A., Killbridge, K.L., Mortazavi, A., Bilen, M.A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Pathologic outcomes after neoadjuvant chemotherapy for high-risk muscle invasive bladder cancer
Matulay, J.T., Campbell, M.T., Narayan, V.M., Seif, M.A., Lim, A.H., Shah, A.Y., Msaouel, P., Gao, J., Siefker-Radtke, A.O., Dinney, C.P.N., Kamat, A.M., Navai, N.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
964P - Lenvatinib (Len) alone or in combination with everolimus (Eve) in heavily pretreated patients (pts) with metastatic renal cell carcinoma (mRCC) after immune checkpoint inhibitors (ICI) and VEGFR-targeted therapies: A single-institution experience
Wiele, A.J., Ross, J., Chahoud, J., Lim, Z., Xiao, L., Campbell, M.T., Shah, A.Y., Zurita Saavedra, A., Jonasch, E., Tannir, N.M.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
924P - Pathologic outcomes after neoadjuvant chemotherapy for high-risk muscle invasive bladder cancer
Matulay, J.T., Campbell, M.T., Narayan, V.M., Seif, M.A., Lim, A.H., Shah, A.Y., Msaouel, P., Gao, J., Siefker-Radtke, A.O., Dinney, C.P.N., Kamat, A.M., Navai, N.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Definitive Radiotherapy for Oligoprogressive Metastatic Renal Cell Carcinoma as a Strategy to Defer Systemic Therapy Escalation
De, B., Venkatesan, A., Msaouel, P., Ghia, A.J., Li, J., Yeboa, D.N., Nguyen, Q.N., Bishop, A.J., Jonasch, E., Shah, A.Y., Campbell, M., Wang, J., Zurita-Saavedra, A., Karam, J., Wood, C., Matin, S., Tannir, N., Tang, C.
Published in International journal of radiation oncology, biology, physics (01.11.2020)
Published in International journal of radiation oncology, biology, physics (01.11.2020)
Get full text
Journal Article
715P Immune checkpoint therapy (ICT) re-challenge after immune-related adverse events (irAEs) in genitourinary cancers (GUC)
Siddiqui, B., Gheeya, J.S., Goswamy, R., Subudhi, S.K., Gao, J., Campbell, M.T., Shah, A.Y., Msaouel, P., Zurita-Saavedra, A.J., Goswami, S., Wang, J., Jonasch, E., Siefker-Radtke, A.O., Sharma, P., Tannir, N.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
710P Phase II trial of lenvatinib (LEN) + pembrolizumab (PEMBRO) for progressive disease after PD-1/PD-L1 immune checkpoint inhibitor (ICI) in metastatic clear cell (mcc) renal cell carcinoma (RCC): Results by independent imaging review and subgroup analyses
Lee, C-H., Shah, A.Y., Hsieh, J.J., Rao, A., Pinto, A., Bilen, M.A., Cohn, A.L., Di Simone, C., Shaffer, D.R., Girones Sarrio, R., Gunnestad Ribe, S., Wu, J., Schmidt, E., Kubiak, P., Okpara, C.E., Smith, A.D., Motzer, R.J.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Phase II study of lenvatinib plus pembrolizumab for disease progression after PD-1/PD-L1 immune checkpoint inhibitor in metastatic clear cell renal cell carcinoma (mccRCC): Results of an interim analysis
Lee, C.-H., Shah, A.Y., Makker, V., Taylor, M.H., Shaffer, D., Hsieh, J.J., Cohn, A.L., DiSimone, C., Marin, A Pinto, Rasco, D.W., Ribe, S.G., Richards, D.A., Stepan, D.E., Dutcus, C.E., Wu, J., Schmidt, E.V., Perini, R.F., Motzer, R.J.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1187PD - Phase II study of lenvatinib plus pembrolizumab for disease progression after PD-1/PD-L1 immune checkpoint inhibitor in metastatic clear cell renal cell carcinoma (mccRCC): Results of an interim analysis
Lee, C.-H., Shah, A.Y., Makker, V., Taylor, M.H., Shaffer, D., Hsieh, J.J., Cohn, A.L., DiSimone, C., Marin, A Pinto, Rasco, D.W., Ribe, S.G., Richards, D.A., Stepan, D.E., Dutcus, C.E., Wu, J., Schmidt, E.V., Perini, R.F., Motzer, R.J.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
963P - A pilot study of tremelimumab (treme) with or without cryoablation (cryo) in patients (pts) in metastatic renal cell carcinoma (mRCC)
Campbell, M.T., Martin, S., Tam, A.L., Sheth, R.A., Singh, S., Ahrar, K., Slack Tidwell, B., Rao, P., Karam, J.A., Wood, C.G., Tannir, N.M., Jonasch, E., Gao, J., Shah, A.Y., Blando, J.M., Duan, F., Basu, S., Allison, J., Sharma, P.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
A pilot study of tremelimumab (treme) with or without cryoablation (cryo) in patients (pts) in metastatic renal cell carcinoma (mRCC)
Campbell, M.T., Martin, S., Tam, A.L., Sheth, R.A., Singh, S., Ahrar, K., Slack Tidwell, B., Rao, P., Karam, J.A., Wood, C.G., Tannir, N.M., Jonasch, E., Gao, J., Shah, A.Y., Blando, J.M., Duan, F., Basu, S., Allison, J., Sharma, P.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article